The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A once-a-week injection that can offer ‘complete viral-load suppression’ for up to 17 months, could be available from 2017 according to Pharmaceutical company CytoDyn Inc. following a trial of 23 patients.
HIV still replicates within the lymphoid tissues, even when people are on antiretroviral treatment and have an undetectable viral load, according to scientists at Northwestern University in the USA.
This new research, published in the journal Nature (January 27), provides valuable insight into why and how HIV remains so difficult to treat and cure.
Family planning is not only about the rights of women and girls to make their own choices about having children and looking after their reproductive health, it's also key to global development.
People living with HIV with suppressed viral loads may, for the first time, be offered long-acting, injectable antiretroviral treatment, following a clinical investigation by two global pharmaceutical companies.